Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Sandoz Among Winners As US Court Applies Tecfidera Patent Invalidity Ruling
Delaware Court Matches Mylan West Virginia Invalidity Decision
Sep 17 2020
•
By
Dean Rudge
Tecfidera ANDA sponsors have much to gain given the value of the US market • Source: Shutterstock
More from Legal & IP
More from Generics Bulletin